RLAY Stock: Price, Earnings History and SEC Filings
Relay Therapeutics, Inc. (RLAY) last traded at $18.35, down 5.75% on the latest session and up 1.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.41 against an analyst estimate of $-0.41, a beat of 0.0%.
$18.35 -5.75%
1 month+1.66%
52-week high$21.27
52-week low$5.95
Volume3.60M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
RLAY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.41 | $-0.41 | +0.00% |
| Mar 2026 | May 5, 2026 | $-0.41 | $-0.35 | -17.14% |
| Dec 2025 | Feb 26, 2026 | $-0.32 | $-0.38 | +15.79% |
| Sep 2025 | Nov 6, 2025 | $-0.43 | $-0.39 | -10.26% |
RLAY beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for RLAY
SEC filing data is not available right now. You can search for RLAY on SEC EDGAR.
RLAY news
- Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026Oct 28, 2026 · finance.yahoo.com
- Tango Therapeutics (TNGX) vs. CRSP and SMMT: Can Vopimetostat Turn Promising Cancer Data Into an 89% Upside?Oct 28, 2026 · finance.yahoo.com
About Relay Therapeutics, Inc.
Relay Therapeutics, Inc. (RLAY) is a US-listed public company on Nasdaq.